Table 2.
Surgicopathologic characteristics of patients.
| Mean (range) | |
|---|---|
| Age at diagnosis | 61.5 years (40–85) |
| MT | 20 mm (8–40) |
| DOI | 14 mm (5–32) |
| TFD | 6 mm (1–17) |
| TD | 35 mm (15–65) |
| %MI | 70% (50–95) |
| Follow-up time | 95.1 months (10–214) |
| Recurrence time | 37.6 months (9–84) |
| n (%) | |
| FIGO grade | |
| 1 | 6 (4.5%) |
| 2 | 97 (72.9%) |
| 3 | 30 (22.6%) |
| Cytology | |
| Positive | 1 (0.8%) |
| Negative | 132 (99.2%) |
| LVSI | |
| Present | 66 (49.6%) |
| Absent | 67 (50.4%) |
| Recurrence | |
| Yes | 9 (6.8%) |
| No | 124 (93.2%) |
| Death | |
| Yes | 2 (1.5%) |
| No | 131 (98.5) |
MT: myometrial thickness; DOI: depth of invasion; TFD: tumor-free distance; TD: tumor diameter; %MI: percentage of myometrial invasion; LVSI: lymphovascular space invasion; FIGO: International Federation of Gynecology and Obstetrics.